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Connexin 43 (Cx43), the principal gap junction protein in vascular smooth muscle cells
(VSMCs), regulates movement of ions and other signaling molecules through gap junction
intercellular communication (GJIC) and plays important roles in maintaining normal vessel
function; however, many of the signaling mechanisms controlling Cx43 in VSMCs are not
clearly described. The goal of this study was to investigate mechanisms of Cx43 regula-
tion with respect to VSMC proliferation. Treatment of rat primary VSMCs with the cAMP
analog 8Br-cAMP, the soluble guanylate cyclase (sGC) stimulator BAY 41-2272 (BAY), or the
Cx inducer diallyl disulfide (DADS) significantly reduced proliferation after 72 h compared
with vehicle controls. Bromodeoxyuridine uptake revealed reduction (p<0.05) in DNA
synthesis after 6 h and flow cytometry showed reduced (40%) S-phase cell numbers after
16 h in DADS-treated cells compared with vehicle controls. Cx43 expression significantly
increased after 270 min treatment with 8Br-cAMP, 8Br-cGMP, BAY or DADS. Inhibition of
PKA, PKG or PKC reversed 8Br-cAMP-stimulated increases in Cx43 expression, whereas
only PKG or PKC inhibition reversed 8Br-cGMP- and BAY-stimulated increases in total Cx43.
Interestingly, stimulation of Cx43 expression by DADS was not dependent on PKA, PKG or
PKC. Using fluorescence recovery after photobleaching, only 8Br-cAMP or DADS increased
GJIC with 8Br-cAMP mediated by PKC and DADS mediated by PKG. Further, DADS signif-
icantly increased phosphorylation at MAPK-sensitive Serine (Ser)255 and Ser279, the cell
cycle regulatory kinase-sensitive Ser262 and PKC-sensitive Ser368 after 30 min while 8Br-
cAMP significantly increased phosphorylation only at Ser279 compared with controls.This
study demonstrates that 8Br-cAMP- and DADS-enhanced GJIC rather than Cx43 expres-
sion and/or phosphorylation plays important roles in the regulation of VSMC proliferation
and provides new insights into the growth-regulatory capacities of Cx43 in VSM.
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INTRODUCTION
Coordination of vascular cell responses is necessary for normal
vessel function and is largely regulated by ionic intercellular cou-
pling via gap junctions. Gap junctional intercellular communica-
tion (GJIC) uniquely allows the cellular exchange of metabolites,
ions, and other small molecules such as second messengers which
play important roles in transverse and longitudinal signaling in the
vascular bed (Coutinho et al., 2003; Liao et al., 2007; Chadjichristos
et al., 2008). Intercellular communication through gap junctions
in cardiovascular tissues is involved in diverse processes such as
determination of vasomotor tone, cell differentiation, growth con-
trol, embryonic development, and coordination of contraction
of cardiac muscle cells (Yamasaki et al., 1996; Liao et al., 2007;
Chadjichristos et al., 2008). Bidirectional cellular communica-
tion conducted by gap junctions is also believed to be integral
in acetylcholine-induced vasoconstriction (Figueroa and Duling,
2009) and in maintaining cell quiescence (Zhang et al., 2003).
Gap junctions are comprised of connexin (Cx) proteins
(Kumar and Gilula, 1996; Yamasaki and Naus, 1996) and serve
as transmembrane channels that act as intercellular conduits for
GJIC. In the vasculature, gap junction channels are formed from
combinations of one or more of the four connexin protein isomers:
Cx37, 40, 43, and/or 45 (Little et al., 1995; Evans and Martin, 2002;
Johnstone et al., 2009) and the predominant connexin in vascular
smooth muscle (VSM) is Cx43 (Haefliger et al., 2004; Saitongdee
et al., 2004; Isakson et al., 2006). Reduction in Cx43 protein expres-
sion and functionality have been associated with enhanced VSM
cell (VSMC) proliferation and differentiation in atherosclerotic
plaques (Kwak et al., 2002); however, the mechanisms for altered
Cx43 expression in atherogenesis have not been well described but
are thought to contribute to its disease progression. Studies have
demonstrated that loss of Cx43 (Solan et al., 2003; Shao et al., 2005;
Norris et al., 2008) or altered Cx phosphorylation status (Dang
et al., 2006; Solan and Lampe, 2007) is sufficient to enhance the
proliferative capacity of cells. Cx43 may undergo multiple phos-
phorylation events and at least five phosphorylated Serines (Ser)
have been detected on Cx43 isolated from non-stimulated cells
and several more have been identified under growth
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factor- or kinase-stimulated conditions (Lampe and Lau, 2004).
These phosphorylation events correlate with changes in assembly
and degradation of Cx43 gap junction channels and thus could
play important roles in regulating GJIC (Cooper et al., 2000), yet
their physiological significance particularly inVSM remains largely
uncharacterized.
Cyclic AMP (cAMP) and cyclic GMP (cGMP) are ubiquitous
second messengers that are involved in a variety of functions dur-
ing vascular homeostasis and following injury or disease; however,
the exact roles for cAMP and cGMP in the regulation of connex-
ins and GJIC are not clear. It has been reported that activation of
the nitric oxide (NO)/cGMP system induces Cx43 expression and
increases GJIC (Yao et al., 2005), yet full characterization of cAMP
and cGMP and their physiological influence on Cx43 expression
and functionality in VSM is warranted.
The overall objective of the present study was to determine the
relation between Cx43 expression, functionality, and phosphory-
lation states with respect to cell proliferation in VSMCs in the
presence of cAMP and cGMP analogs and in comparison to the
indirect soluble guanylate cyclase (sGC) stimulator BAY 41-2272
(BAY) and the Cx43 stimulant and garlic compound diallyl disul-
fide (DADS). In summary, results from this study show that an
increase in Cx43-mediated GJIC is essential for control of prolif-
eration in primary VSMCs and that enhanced expression and/or
differential phosphorylation of Cx43 alone do not serve as effec-
tive growth regulators. Moreover, evidence is presented supporting
roles for 8Br-cAMPand DADS and physiologically effective agents
in the control of VSM growth.
MATERIALS AND METHODS
ISOLATION AND CULTURE OF RAT PRIMARY VSMCs
This study abided by the guidelines of the East Carolina Uni-
versity Animal Care and Use Committee and conformed to
the Guide for the Care and Use of Laboratory Animals (US
NIH, Pub. No. 85–23, rev. 1996). Male Sprague-Dawley rats
(100–125 g) were anesthetized [ketamine (90 mg/ml), xylazine
(10 mg/ml; 1 ml/kg, i.p.)] and euthanized by pneumothorax
and exsanguination. Vascular SMCs (VSMCs) were harvested
from the thoracic aorta and isolated by collagenase and elas-
tase digestion as described (Durante et al., 1993; Liu et al.,
2009). Cells were cultured serially (passage 1–6) in Dulbecco’s
minimum essential media (DMEM) supplemented with 10%
fetal bovine serum (FBS), 2 mM l-glutamine, sodium pyruvate,
5 mM HEPES, and Primocin (100 mg/l) in the presence of 95%
air/5% CO2.
TREATMENTS
Unless otherwise stated, VSMCs were treated with 8Br-cAMP
or 8Br-cGMP (Adderley et al., 2012) at 100µM, BAY 41-2272
at 100 nM, or DADS at 50µM. For treatments involving kinase
inhibition, VSMC were treated with PKI (10µM; Schlegel and
Waschke, 2009) for inhibition of PKA, DT2 (YGRKKRRQRRRPP-
LRKKKKKH-amide; 10µM; Dostmann et al., 2002; Dey
et al., 2005) to inhibit PKG, or calphostin-C (CalC; 100 nM;
Touyz and Schiffrin, 1997) to inhibit PKC for 15 min prior
to treatment with vehicle, 8Br-cAMP, 8Br-cGMP, BAY, or
DADS.
MTT ASSAY
Vascular smooth muscle cells were plated onto 96-well plates at
21,000 cells/well and treated with 8Br-cAMP, 8Br-cGMP, BAY, or
DADS. After 12 or 72 h 2,5-diphenyltetrazolium bromide (MTT)
solution was added to the media and the cells incubated for 3 h. The
MTT-containing media was discarded and the cells were gently
washed with PBS. Formazan formed within the cells was then dis-
solved in acetic-isopropanol and the plate was read at 570 nm with
correction at 750 nm. The optical density (OD) of the treatments
was normalized to vehicle controls.
HEMOCYTOMETRY AND NEUTRAL RED UPTAKE
Hemocytometry was performed after 72 h to obtain viable cell
numbers and Neutral Red Uptake was performed after 12 h as an
estimate of cellular toxicity per established protocols (Mendelev
et al., 2009; Joshi et al., 2011).
BrdU UPTAKE
The rate of DNA synthesis was measured with 5-bromo-2′-
deoxyuridine (BrdU) labeling (Giordano et al., 2008) with detec-
tion (Detection Kit II, Roche Diagnostics Corporation, Indianapo-
lis, IN, USA) following manufacturer’s instructions. Briefly, cells
were plated onto 96-well plates at 21,000 cells/well. After quiescing
overnight, cells were treated with 8Br-cAMP, 8Br-cGMP, BAY, or
DADS for 2 h followed by BrdU treatment for 4 h. Cells were fixed
and incubated in the presence of the anti-BrdU antibody for 1 h,
after which the antibody was removed and the detection reagent
added. The plate was read on a spectrophotometer at 370 nm with
a reference at 492 nm. The OD of the treatments was normalized
to vehicle controls.
CELL CYCLE ANALYSIS
Flow cytometric cell cycle analysis was performed as described
(Joshi et al., 2011). Briefly, VSMCs were seeded in 24-well plates
(100,000 cells/well) and after adherence were quiesced overnight
in DMEM containing 0.2% FBS. Cells were treated with vehicle,
8Br-cAMP or DADS for 16 h. The cells were trypsinized, fixed in
cold ethanol, stained with propidium iodide, and subjected to flow
cytometry (Accuri C6).
IN-CELL WESTERN BLOTTING
The effects of 8Br-cAMP, 8Br-cGMP, BAY, or DADS alone or in the
presence of PKA, PKG, or PKC inhibitors PKI, DT2, or CalC on
Cx43 expression in VSMCs were studied using the in-cell Western
(ICW) method (Chen et al., 2005). Primary VSMCs were seeded
in black 96-well flat bottom plates at 21,000 cells/well and fol-
lowing attachment were treated with respective agents for 30 or
270 min or 24 h. For inhibitor studies, VSMCs were pretreated for
15 min with PKI (10µM), DT2 (10µM), or CalC (100 nM) fol-
lowed by treatment with 8Br-cAMP, 8Br-cGMP, BAY, or DADS
for 270 min. Reactions were stopped by replacing media with
4% phosphate-buffered formalin. Fixed cells were permeabilized
with 0.1% Triton, blocked, and incubated with IR-tagged rabbit
antibodies against Cx43 or the phosphorylated forms of Cx43 at
Serines 255, 262, 279, and 368 (Cell Signaling) along with mouse
α-tubulin (Sigma) as the housekeeping control at 1:500 dilutions
overnight at 4˚C. Cells were washed with PBS-Tween and incu-
bated with anti-rabbit IR 800 and anti-mouse IR 680 (Rockland)
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secondary antibodies for 1 h. The proteins were quantified by
fluorescence (LiCor Odyssey) and normalized with respect to α-
tubulin within each well. All treatments were normalized to vehicle
control.
WESTERN BLOTTING
Western blotting was performed on whole cell lysates as previ-
ously described (Mendelev et al., 2009) with slight modifications.
After treatment with 8Br-cAMP, 8Br-cGMP, BAY, or DADS for
270 min, cells were collected, homogenized, sonicated, boiled, and
SDS-PAGE was performed using 20µg protein samples. The sepa-
rated blots were transferred to nitrocellulose membrane, blocked,
and incubated overnight at 4˚C with IR-tagged antibodies against
rabbit Cx43 protein (Millipore) and mouse α-tubulin (Sigma)
at 1:3000 dilutions. After washes the membranes were incubated
in anti-rabbit IR800 and anti-mouse IR680 secondary antibodies
(Rockland; 1:3000) for 1 h at room temperature. Blots were washed
and proteins were quantified by fluorescence densitometry (Li-Cor
Odyssey) and normalized with respect to α-tubulin.
GAP JUNCTION COMMUNICATION
Gap junction-mediated cell–cell communication was measured
using a fluorescence recovery after photobleaching (FRAP) assay
as described (Goodwin and Kenworthy, 2005; Shen et al., 2010)
with slight modifications. In this assay, recovery of fluorescence in
a previously bleached cell is the result of influx of native dye from
neighboring cells via gap junctions (Wade et al., 1986; Muller-
Borer et al., 2004; Shen et al., 2010). Thus, the FRAP assay is a
direct measure of gap junction permeability and conductance and
is a reliable measure of GJIC functionality. Moreover, FRAP is
non-invasive, highly sensitive, and faster compared to more tra-
ditional GJIC approaches such as microinjection and dye transfer
(Shen et al., 2010). Lastly, in this study FRAP measurements were
performed after 15-min treatment, a physiologically relevant time
point for the measurement of acute changes in gap junction func-
tion. Briefly, FRAP was performed using a laser scanning confocal
microscope (Leica TCS-SP, Heidelberg, Germany), mounted on a
Leica inverted microscope with a 63× water objective. Primary
VSMCs were seeded (∼35,000 cells) and grown to confluence on
glass coverslips. For the loading of Calcein AM (Invitrogen), cells
were washed with warm PBS and incubated in phenol-free DMEM
containing Calcein AM (1µM) for 45 min, washed with warm PBS
and incubated in 10% FBS in DMEM. Cells were treated for 15 min
with either 8Br-cAMP, 8Br-cGMP, BAY, or DADS and subjected to
FRAP. In the inhibitor study with 8Br-cAMP and DADS, 15 min
treatment of the respective PKA, PKG, and PKC inhibitors PKI
(10µM), DT2 (10µM), or CalC (100 nM) was followed by treat-
ment with 8Br-cAMP or DADS. Individual cells connected with
at least four cells on all the sides were selected for photobleaching.
Calcein AM (Invitrogen Corp, Carlsbad, CA, USA) was excited
by a high intensity argon laser pulse at 488 nm to bleach intra-
cellular Calcein in selected cells and captured through grating at
530/30 nm. The bleached cell was then monitored, and images
were acquired continuously every 10 s for the initial minute, fol-
lowed by 30 second intervals for 2 minutes and 1 minute intervals
for another 2 minutes. GJIC between a cell and its neighbors
was quantified by measuring the initial rate and percentage of
fluorescence recovery. Non-photobleached cells were monitored as
controls for spontaneous photobleaching. The rate of fluorescence
recovery was estimated using the Zen (2009) software (Carl Zeiss)
and the initial recovery rate constants were compared between the
treated and vehicle controls. All treatments were normalized to
vehicle control and expressed as percentage of vehicle controls.
STATISTICAL ANALYSES
Data were analyzed using Microsoft Excel 2007 and Sigma Plot
11 (SPSS, Inc.). Comparisons between treatment groups were
made using one-way analysis of variance (ANOVA) and a mul-
tiple comparison Newman–Keuls post hoc test or Student’s t -test
as indicated. All data are presented as mean± SEM. A p-value of
<0.05 is considered statistically significant for all comparisons.
RESULTS
VSMC GROWTH
Growth of VSMCs was assessed through use of the MTT assay
and hemocytometric cell counts after 72 h, flow cytometry after
16 h, and BrdU incorporation after 6 h. Mitochondrial dysfunction
and cellular toxicity from all treatments were also evaluated after
12 h. Using the MTT assay after 72 h, 8Br-cAMP (100µM), BAY
(100 nM), or DADS (50µM) significantly reduced VSMC prolif-
eration compared with vehicle controls; however, 8Br-cGMP was
without effect (Figure 1A). In agreement, hemocytometry after
72 h also revealed significant reduction in cell numbers following
treatment with 8Br-cAMP (100µM) or BAY (100 nM), and a non-
significant trend (∼20% reduction; p= 0.06) was observed for the
DADS treatment group (Figure 1B). The MTT assay performed
after 12 h indicated no observable mitochondrial dysfunction in
any cohort (Figure 1C). Similarly, Neutral Red Uptake after 12 h
showed no significant differences between treatment and vehicle
control groups (data not shown).
Following BrdU uptake for 6 h, DADS (50µM) significantly
reduced (20%) the rate of DNA synthesis compared with vehicle
controls (Figure 2), yet 8Br-cAMP, 8Br-cGMP, or BAY showed no
effects on DNA synthesis at this time point.
Flow cytometry performed as a measure of cell cycle progres-
sion showed that DADS significantly reduced the number of cells
in the S-phase (∼40%) compared with vehicle controls after 16 h,
while 8Br-cAMP caused non-significant decreases in cell numbers
in the S and G2/M phases and a non-significant increase in G0/G1
cells (Figure 3).
Cx43 EXPRESSION
Using both IR-based Western and ICW analyses, incubation of rat
primary VSMCs with 8Br-cAMP or 8Br-cGMP (100µM), BAY
(100 nM), or DADS (50µM) significantly increased total Cx43
expression (normalized to α-tubulin) compared with vehicle con-
trols after 270 min (Figure 4). Figure 4A shows densitometry
results following ICW, and all agents increased total Cx43 by 20–
25%. Interestingly, after 24 h only DADS significantly increased
total Cx43 expression (Figure 4B). Of note, reducing the incu-
bation period to 30 min in the presence of the four compounds
showed no changes in Cx43 expression (data not shown). Using
traditional, IR-Western blotting, the same trends were observed
for increased total Cx43 expression (data not shown), yet the
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FIGURE 1 | Effects of cyclic nucleotide or Cx43 stimulation on
VSMC proliferation. (A) In rat primary VSMCs in the presence of 10%
serum for 72 h and using the MTT assay, 8Br-cAMP (100µM), the sGC
stimulator BAY (100 nM) or the garlic-derived Cx inducer DADS (50µM)
significantly reduced rat primary VSMC numbers compared with
vehicle controls. Data are mean±SEM with an n= 6. (B) Using
hemocytometry after 72 h, both 8Br-cAMP and BAY significantly
reduced cell numbers by ∼40%, and the presence of DADS reduced
cell numbers by ∼20% (p=0.06). Data are mean±SEM of two
independent experiments each with n=3–4. (C) MTT assay performed
on VSMCs after 12 h shows no observable changes in any treatment
group. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p<0.05 compared with
normalized vehicle controls.
FIGURE 2 | Effects of cyclic nucleotide or Cx43 stimulation on VSMC
DNA synthesis. In rat primary VSMCs in the presence of 10% serum for
6 h, DADS (50µM) significantly reduced the rate of DNA synthesis by 20%
compared with vehicle controls estimated by BrdU incorporation. Data are
mean±SE from three independent experiments each with an n=6.
Student–Newman–Keuls method for multiple comparisons following
one-way ANOVA was used. *p<0.05compared with normalized vehicle
controls.
extent of increases was much higher than that observed with
ICW. A representative IR-Western blot for total Cx43 expression is
shown in Figure 4C. Figure 4D shows a representative photomi-
crograph of confluent VSMCs following immunocytochemical
staining for Cx43 which shows punctate presence of gap junctions
predominantly at cell-to-cell contacts (indicated by arrows).
EFFECTS OF KINASE INHIBITION ON STIMULATED Cx43 EXPRESSION
Kinase regulation of Cx43 expression in the presence of 8Br-cAMP,
8Br-cGMP, BAY, or DADS was tested using selective kinase block-
ade and evaluated through ICW analysis. Respective inhibition
of PKA, PKG, and PKC by PKI, DT-2, and CalC significantly
reversed the stimulatory effects of 8Br-cAMP on total Cx43 expres-
sion (Figure 5A). In comparison, only the inhibition of PKG and
PKC (by DT-2 and CalC, respectively) reversed the stimulation of
Cx43 expression induced by both the direct-activating 8Br-cGMP
(Figure 5B) and the indirect sGC stimulator BAY (Figure 5C).
Inhibition of any of the kinases, PKA, PKG, or PKC, did not
have any effect on DADS-induced stimulation of Cx43 expres-
sion (Figure 5D). Lastly, each inhibitor alone failed to alter basal
(vehicle-treated) total Cx43 expression (Figure 5E). A summary
of results from the kinase inhibitor studies on Cx43 expression is
shown in Table 1.
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FIGURE 3 | Effects of 8Br-cAMP and DADS on 10% FBS-stimulated
VSMC cell cycle progression. Using flow cytometry after 16 h incubation,
a 40% reduction in the percentage of cells in the S-phase was observed in
the presence of DADS (50µM) with no significant changes in the G0/G1 or
G2/M phases compared with vehicle controls. Data are mean±SEM with
an n=3. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p<0.05compared with vehicle
controls.
CELL-TO-CELL COMMUNICATION
Using FRAP as a measure of GJIC and gap junction function-
ality, incubating cells for 15 min in the presence of 8Br-cAMP
increased GJIC by 50% and in the presence of DADS by 80%
over vehicle controls while the presence of 8Br-cGMP or BAY
had no effect (Figure 6A). After 270 min 8Br-cAMP or DADS
failed to enhance GJIC (data not shown). Representative pho-
tomicrographs of adherent VSMCs subjected to FRAP analysis
are shown (Figures 6B–E) with the photobleached cell of interest
outlined. Figure 6B shows a cell immediately prior to photobleach-
ing; Figure 6C shows that cell immediately after photobleaching;
Figure 6D shows the cell 2.5 min after photobleaching and some
degree of fluorescent recovery is apparent; Figure 6E shows the
cell 4.5 min after photobleaching at the conclusion of fluorescence
recovery.
To examine kinase involvement in the acute stimulation of
GJIC by 8Br-cAMP or DADS, FRAP was studied following select
kinase inhibition in the presence of 8Br-cAMP or DADS. GJIC
stimulated by 8Br-cAMP was reversed by PKC inhibition alone
(Figure 7A), whereas GJIC stimulated by DADS was markedly
subdued (p= 0.06) by DT-2-mediated inhibition of PKG alone
(Figure 7B).
Cx43 PHOSPHORYLATION
Site-specific phosphorylation of Cx43 was studied at four sites
known to be sensitive to kinase activation: Ser255 and Ser279
(MAPK-specific), Ser262 (p34cdc2 kinase-specific), and Ser368
(PKC-specific). In the presence of 8Br-cAMP, phosphorylation of
Cx43 increased (∼20–30%) at both MAPK-sensitive sites (Ser255
and Ser279) compared with vehicle controls, reaching statisti-
cal significance at the Ser279 site (Figure 8A). In comparison,
DADS significantly increased (∼30%) phosphorylation at MAPK-
sensitive Ser255 and Ser279, the p34cdc2-sensitive Ser262, and the
PKC-sensitive Ser368 (Figure 8B).
DISCUSSION
Accumulating evidence indicates a regulatory role for connexins
and gap junction communication in a variety of vascular patholo-
gies including hypertension (Figueroa et al., 2006; Brisset et al.,
2009) ischemia/reperfusion injury (Jara et al., 1995), atheroscle-
rosis (Blackburn et al., 1995; Polacek et al., 1997; Yeh et al., 1997),
and the growth response to vascular injury (Yeh et al., 1997; Kur-
jiaka et al., 1998; Brisset et al., 2009). Mechanistically, a variety of
controlling elements have been examined for Cx (Figueroa and
Duling, 2009), yet few reports have investigated a role for cyclic
nucleotides in the control of Cx43 expression and functionality
with respect to VSM growth. Hence, this study aimed to under-
stand the physiological relevance of Cx43 regulation by cyclic
nucleotide signaling in VSM growth. Using rat primary VSMCs,
the cyclic nucleotide analog 8Br-cAMP and the garlic-derived dial-
lyl compound DADS reduced proliferation and DNA synthesis and
increased Cx43 expression and functionality, establishing a direct
link between VSMC proliferation and Cx43. It was also observed
that distinct protein kinase signals have capacity to regulate Cx43
expression and functionality that are modulated by 8Br-cAMP
and DADS. In summary, this study provides direct evidence for
the mechanistic basis of gap junctional communication in the
regulation of VSMC proliferation.
In this study both metabolically stable, direct-activating cyclic
nucleotide analogs and indirect sGC stimulation were used to
induce cyclic nucleotide signaling. Using 8Br-cAMP and 8Br-
cGMP, after a 72-h exposure only 8Br-cAMP significantly reduced
cell proliferation estimated by the MTT and hemocytometry
assays, confirming an earlier report using a different cAMP ana-
log (Indolfi et al., 2000). In the current study it was interesting to
note that 8Br-cGMP failed to exert noticeable effects on VSMC
growth as earlier studies report anti-proliferative effects by stimu-
lation of cGMP-related pathways (Lincoln et al., 2006) but not
by cGMP per se. To complement findings from the prolifera-
tion assays, two additional approaches were employed to examine
VSMC growth. Bromodeoxyuridine uptake allows study of DNA
synthesis whereas flow cytometry explores cell cycle progression.
Most reports studying the effects of cGMP on VSMC prolifera-
tion involve indirect cGMP stimulation that may have untoward
effects such as those mediated by cAMP considering that cGMP-
mediated inhibition of PDE3 increases cAMP levels (Maurice and
Haslam, 1990). Remarkably, neither 8Br-cAMP nor 8Br-cGMP
showed influence on the rate of DNA synthesis estimated by BrdU
uptake after 6 h. Nonetheless, using flow cytometry 8Br-cAMP
showed insignificant decreases in S-phase and G2/M phase cells
with a slight increase in G0/G1 cells after 16 h. The effects on
the nuclear mechanisms in the presence of 8Br-cAMP were not
evident at the acute time points analyzed; nonetheless, the inhibi-
tion of VSMC growth after 72 h was significant confirming earlier
reports that elevated cAMP inhibits VSMC proliferation in vitro
(Wu et al., 2006).
Recent findings from our lab provide solid evidence that phar-
macologic sGC stimulation increases both cAMP and cGMP
(Adderley et al., 2012) and inhibits neointimal growth after bal-
loon injury (Joshi et al., 2011). In the current study in comparison
to the effects of the cyclic nucleotide analogs, the sGC stimulator
BAY 41-2272 (BAY) did not significantly reduce DNA synthesis but
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FIGURE 4 |Total Cx43 expression in VSMCs. (A) In-cell Western blotting for
total Cx43 expression in rat primary VSMC homogenates. Incubation of rat
primary VSMCs for 270 min in the presence of 8Br-cAMP (100µM), 8Br-cGMP
(100µM), BAY (100 nM), or DADS (50µM) significantly stimulated total Cx43
expression normalized to α-tubulin. Data are from two independent
experiments each performed in triplicate. (B) After 24-h incubation the
stimulation of Cx43 was significantly increased only after DADS treatment
with no observable changes for the 8Br-cAMP, 8Br-cGMP, or BAY treatment
groups compared with vehicle controls. For these experiments n= 6 for each
treatment. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p<0.05 compared with normalized
vehicle controls. (C) A representative Western blot showing total Cx43 in
green and α-tubulin in red using IR-labeled antibodies. These data were
obtained from a single Western blot with a column (unrelated to the current
study) removed for clarity. (D) Photomicrograph of confluent VSMCs following
immunocytochemical staining for total Cx43. Punctate appearance of Cx43
indicating the presence of gap junctions is predominantly at cell-to-cell
contacts (indicated by arrows).
reduced VSMC proliferation after 72 h as reported earlier (Joshi
et al., 2011). This anti-proliferative effect of BAY was recently sug-
gested to occur through Cdk suppression and elevation of p21
and p27 (Mendelev et al., 2009); however, that study used BAY
at 10µM in commercial A7R5 VSMCs whereas the present study
used BAY at 100 nM in primary VSMCs. Additionally, this current
study and our recent report (Joshi et al., 2011) attribute decreases
in VSMC proliferation induced by BAY to changes in phospho-
rylation of vasodilator-activated serum phosphoprotein (VASP),
a marker of differential kinase activation (Butt et al., 1994), and
a critical cytoskeletal and focal adhesion element (Reinhard et al.,
2001).
In the current study a significant reduction in VSMC growth
and DNA synthesis by DADS was complemented by a decrease
in the number of cells in the S-phase, estimated by flow cytom-
etry. The inhibitory effects of DADS on cell growth in other
systems have been mostly attributed to an increase in the apoptotic
cell populations correlated with depressed p34cdc2 kinase activity
(Knowles and Milner, 2000), and at the same time DADS has been
reported to be a potent stimulator of Cx43 expression and activity
(Huard et al., 2004). DADS has been reported to induce S-phase
block in tumorigenic CNE2 cells (Zhang et al., 2006), observed in
the present study in VSMCs as well.
Expression of Cx43 has been reported to be regulated by
cAMP in thymic epithelial cells (Nihei et al., 2010), but scien-
tific evidence is lacking for the effects of cAMP or cGMP on
Cx43 expression and functionality in primary VSM. The present
study exclusively used primary VSMCs to study the effects of the
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FIGURE 5 | Results from in-cell Western analyses showing effects of
kinase inhibition on total Cx43 expression in rat primary VSMCs
following incubation in the presence of (A) 8Br-cAMP (100µM), (B)
8Br-cGMP (100µM), (C) BAY (100 nM), and (D) DADS (50µM) for 270 min.
(A) Inhibition of PKA (by PKI), PKG (by DT2), or PKC (by CalC) each
independently subdued 8Br-cAMP-induced increase in Cx43 expression. (B,C)
Only PKG and PKC inhibition reversed the effects of 8Br-cGMP and BAY,
respectively. (D) Stimulation of Cx43 expression in the presence of DADS was
not dependent on PKA, PKG, or PKC. (E) Treatment with any individual kinase
inhibitor did not affect total basal Cx43 expression compared with vehicle
controls. Data are mean±SE from n=4–7 for each treatment.
Student–Newman–Keuls method for multiple comparisons following one-way
ANOVA was used. *p<0.05 compared with normalized vehicle controls;
#p<0.05 comparing inhibitors to agonists alone normalized to vehicle controls.
brominated cyclic nucleotide analogs and BAY on Cx43 expres-
sion/functionality and to investigate the roles of PKA, PKG, and
PKC in mediating these events. Both 8Br-cAMP and 8Br-cGMP
stimulated total Cx43 protein expression providing direct evi-
dence for the regulation of Cx43 by cyclic nucleotides in VSMCs.
These cyclic nucleotide analogs are known to act via kinase path-
ways. The known inhibitors PKI, DT-2, and CalC were used for
respective inhibition of PKA, PKG, and PKC, and inhibition of all
the three individual kinases reversed 8Br-cAMP-stimulated Cx43
expression, providing direct evidence for the role of all the three
kinases in 8Br-cAMP-mediated stimulation of Cx43 expression.
At the same time an involvement of only the PKG and PKC path-
ways was evident in 8Br-cGMP stimulation of Cx43 expression
as only DT-2 and CalC reversed 8Br-cGMP-mediated stimulation
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Table 1 |Table showing the summary of the effect of 8Br-cAMP,
8Br-cGMP, BAY, and DADS on Cx43 expression and the regulation of
this Cx43 stimulation by the respective kinases.
Kinase inhibitors
Treatment Total
Cx43
expression
w/PKI
(PKA
inhibition)
w/DT-2
(PKG
inhibition)
w/CalC
(PKC
inhibition)
8Br-cAMP ↑ ↓ ↓ ↓
8Br-cGMP ↑ – ↓ ↓
BAY 41-2272 ↑ – ↓ ↓
DADS ↑ – – –
of Cx43 expression. This is the first report providing evidence for
involvement of cyclic nucleotide-mediated kinase pathways in the
regulation of Cx43 expression in primary VSM. In comparison
to these direct analogs, the sGC/cGMP stimulator BAY was also
observed to stimulate Cx43 expression that was reversed by the
inhibition of PKG and PKC, the same kinases that were involved in
the stimulation of Cx43 expression by 8Br-cGMP. The diallyl com-
pound DADS is known to stimulate Cx43 in rat liver cells (Huard
et al., 2004), and in the current study was found to increase Cx43
expression and conductance in rat primary VSMCs. Interestingly,
these effects of DADS on Cx43 expression appear independent of
the kinase pathways studied here, namely PKA, PKG, or PKC.
Although 8Br-cAMP, 8Br-cGMP, BAY, and DADS each inde-
pendently increased Cx43 expression, it was only with 8Br-cAMP
and DADS that an increase in GJIC was observed confirming
earlier reports (Huard et al., 2004; Nihei et al., 2010). Although
8Br-cGMP has been observed to increase GJIC in other tissues
such as the mesangium (Yao et al., 2005), similar effects on GJIC
were not observed in the rat primary VSMC in this study. It is
important to note that the increased GJIC reported earlier (Yao
et al., 2005) in the presence of 8Br-cGMP was in the presence
of a very high concentration of analog (500µM) and observed
after a 24-h incubation, whereas in the present study 8Br-cGMP
was used at 100µM for 15 min under more physiologically real-
istic conditions. A high turnover rate (t 1/2 1.5–3.5 h; Laird et al.,
1991) has been observed for plasma membrane-localized Cx43.
Cx43 also possesses multiple phosphorylation sites (Lampe and
Lau, 2000). Thus, the purpose of using a shorter time point was
to avoid potential changes in Cx43 expression levels and to inves-
tigate if rapid phosphorylation of Cx43 coincided with changes in
GJIC. Furthermore, short-term incubation (30 min) in the pres-
ence of 8Br-cAMP, 8Br-cGMP, BAY, or DADS had no effects on the
Cx43 expression levels (data not shown). A number of reports have
shown that increased cAMP increases Cx43 expression, function-
ality, and phosphorylation (Lampe and Lau, 2004) and specifically
the increase in Cx43 expression appears to be mediated by PKA
(Paulson et al., 2000) in hepatoma cells and it has only recently
been reported that the cAMP/PKA pathway regulates GJIC in
mouse embryonic stem cells (Yun et al., 2012). The stimulation
of GJIC by 8Br-cAMP observed in this study was reversed by the
PKC inhibitor CalC, and it was surprising to note that neither PKA
nor PKG had any role in regulating 8Br-cAMP-stimulated GJIC. In
rat primary VSMC crosstalk between the different kinases has been
reported (Adderley et al., 2012; Joshi et al., 2011). Moreover, the
different kinases may play varying roles in regulating Cx43 expres-
sion/functionality depending on their tissue/organ specificity and
perhaps precise localization within the cellular milieu (Adderley
et al., 2012).
In this effort the sGC modulator BAY did not exert noticeable
effects on GJIC in rat primary VSMC. This is the first report study-
ing the influence of BAY on Cx43 expression and functionality,
and although BAY has been reported to inhibit VSMC prolifera-
tion through cGMP-dependent pathways (Mendelev et al., 2009)
it does not seem to be dependent upon a functional Cx43. It could
be possible, however, that the BAY-stimulated increase in Cx43
expression may have delayed effects on VSMC proliferation that
were not evident at the time points observed in this study.
The diallyl garlic compound DADS has been reported to be
cancer chomopreventive in a number of studies (Schaffer et al.,
1996; Knowles and Milner, 2000; Arunkumar et al., 2006) and an
important characteristic of DADS is its ability to stimulate Cx43
expression and GJIC (Huard et al., 2004). There is increasing
evidence that GJIC alteration is involved in tumor cell develop-
ment (Trosko and Ruch, 1998), and most studies using DADS
have been performed on phenotypically modified or tumorigenic
cells. This is the first report characterizing the effects of DADS
on VSMC Cx43 with respect to proliferation, and data reveal that
DADS stimulates acute GJIC. The shorter treatment time used
in this study (15 min) is important as no changes in Cx43 pro-
tein expression were detected even after 30-min exposure, and
thus these findings signify direct, translation-independent acti-
vation of Cx43 leading to the opening of gap junction channels
and promoting GJIC. The inhibition of PKG by DT-2 reversed
DADS-promoted GJIC in the rat primary VSMCs which was not
reversed by either PKA or PKC inhibition. This observation indi-
cates involvement of the PKG pathway in DADS stimulation, and
in comparison with the role for PKC in the activation of GJIC
by 8Br-cAMP, clearly supports the notion of crosstalk between
the kinases that appears to be tissue- and function-specific. The
study also highlights the fact that the functionality of gap junc-
tions plays a more important role in regulating the prolifera-
tion of VSMC than does simple expression of the gap junction
proteins.
Considering the potential involvement of site-specific Cx43
phosphorylation in regulating GJIC that may control cell prolifer-
ation, phosphorylation of Cx43 was studied at the MAPK-sensitive
sites Ser255 and Ser279, the cell cycle regulatory p34cdc2-sensitive
Ser262, and PKC-sensitive Ser368. Although both 8Br-cAMP and
DADS had similar effects on VSMC growth and Cx43 expression
and functionality, they have different site-specific Cx43 phos-
phorylation profiles. Using the ICW technique that is preferred
for evaluation of phosphorylated residues, 8Br-cAMP stimulated
Cx43 phosphorylation at only the MAPK-sensitive Ser255 and
Ser279 sites while DADS stimulated phosphorylation of Cx43 at
multiple sites including Ser255 and Ser279, Ser262 and Ser368.
Studies have demonstrated alteration in the proliferative state of a
cell with a loss of Cx43 (Solan et al., 2003; Shao et al., 2005; Norris
et al., 2008) or its altered phosphorylation status (Dang et al., 2006;
Solan and Lampe, 2007). Changes in Cx43 phosphorylation and
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FIGURE 6 | Gap junction intercellular communication (GJIC) as an
indicator of functionality estimated by fluorescence recovery after
photobleaching (FRAP). (A) Incubation of rat primary VSMCs for 15 min
in the presence of 8Br-cAMP (100µM) or DADS (50µM) significantly
increased GJIC. Data are mean±SE from an n=5–9 for each treatment.
Student–Newman–Keuls method for multiple comparisons following
one-way ANOVA was used. *p< 0.05 compared with normalized vehicle
controls. (B–E) Representative photomicrographs (630×) of confluent
VSMCs undergoing FRAP with the targeted cell outlined. (B) Before
photobleaching; (C) immediately after photobleaching; (D) 2.5 min after
photobleaching; and (E) 4.5 min after photobleaching at the conclusion of
fluorescence recovery.
gap junctional communication have also been observed as cells
proceed through the cell cycle (Koo et al., 1997; Xie et al., 1997;
Kanemitsu et al., 1998; Lampe et al., 1998; Bittman and LoTurco,
1999; Solan et al., 2003), indicating that GJIC and Cx43 phos-
phorylation are tightly regulated and linked during cell cycle. It is
important to note that the role of Cx43 phosphorylation may dif-
fer considerably among cell types, stages of cell cycle, growth factor
milieu and extracellular matrix interactions,and given its short t 1/2
and rapid turnover, its phosphorylative capacity must be closely
regulated. Although a loss of GJIC has been reported in WB-F344
rat liver epithelial cells (Ruch et al., 2001) and in the IAR6.1 rat liver
epithelial cell (Rivedal and Opsahl, 2001) line after TPA treatment
along with Cx43 phosphorylation at the MAPK active sites, Ser255
and Ser279, a similar effect was not seen in the rat primary VSMC
after 8Br-cAMP and DADS. In fact, increased phosphorylation
of Cx43 at Ser255 and Ser279, MAPK-sensitive sites, correlated
with reduced VSMC growth and improved GJIC. Ser262 is a
p34cdc2-sensitive phosphorylation site that has been reported to
be involved in cell division (Laird, 2005). Following phosphory-
lation of Cx43 at Ser262 by p34cdc2 protein kinase, a loss of gap
junction coupling was observed in Rat1 and human endothelial
cells (Lampe et al., 1998). Conversely, in this study in the pres-
ence of DADS an increase in Cx43 phosphorylation at Ser262 and
GJIC in rat primary VSMC was observed with a decrease in pro-
liferation. These differences can be attributed to unique cellular
systems and treatment times, and most importantly, the role of
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FIGURE 7 | Effect of kinase inhibition on (A) 8Br-cAMP- and (B)
DADS-stimulated GJIC estimated by FRAP. Rat primary VSMCs were
incubated for 15 min in the presence of the following PKA, PKG, and
PKC inhibitors: PKI (10µM), DT-2 (10µM), and Calphostin-C (100 nM),
respectively, followed by 8Br-cAMP (100µM) or DADS (50µM) alone
for 15 min. (A) Stimulation of GJIC by 8Br-cAMP was effectively
inhibited by PKC inhibition alone but not by inhibition of PKA or PKG.
(B) DADS-mediated GJIC stimulation was partially (non-significantly)
reversed by PKA or PKG inhibition. Data are mean±SE from an n=4
for the inhibitors treatment and an n=6–9 for control, 8Br-cAMP and
DADS. Student–Newman–Keuls method for multiple comparisons
following one-way ANOVA was used. *p<0.05 compared with
normalized vehicle controls, #p<0.05 compared with cAMP-treated
cells.
FIGURE 8 | In-cell Western analyses of site-specific Cx43
phosphorylation in rat primary VSMCs in the presence of (A)
8Br-cAMP and (B) DADS. (A) In the presence of 8Br-cAMP,
phosphorylation of the MAPK-sensitive Ser279 was significantly increased
compared to vehicle controls. (B) The presence of DADS significantly
increased phosphorylation at the MAPK sensitive Ser255 and Ser279
sites, p34cdc2 kinase-sensitive Ser262, and the PKC-sensitive Ser368. Data
are mean±SE from three independent experiments with an n=4 for
Ser279 phosphorylation, and n=3–4 for Ser255, 262, and 368
phosphorylation. Student–Newman–Keuls method for multiple
comparisons following one-way ANOVA was used. *p<0.05 compared
with respective vehicle controls.
Cx43 phosphorylation may be entirely cell-or tissue-specific that
may also depend on the stages of cell growth.
Phosphorylation of Cx43 on Ser368 is mediated by PKC, and
earlier reports using rat epithelial T51B cells strongly suggest that
PKC directly phosphorylates Cx43 on Ser368 in vivo that con-
tributes to a decrease in intercellular communication (Lampe
et al., 2000) and that promotes carcinogenesis (Berthoud et al.,
1992). These findings have served as the basis for the hypothesis
that reduced cell–cell communication is a critical step in multi-
stage carcinogenesis. The focus of the present study however was
growth of normal VSMC and not modified or cancerous cells.
Contrary to the earlier report (Lampe et al., 2000), in neonatal rat
cardiomyocytes activation of PKC has been reported to cause an
increase in junctional conductance (Kwak et al., 1995). The rea-
son for these differences is not yet explained. In the present study
GJIC stimulated by 8Br-cAMP was mediated by PKC, while that
by DADS appeared to be mediated by PKG. Although 8Br-cAMP
did not have any effects on the PKC-sensitive phosphorylation
site Ser368 on Cx43, DADS significantly increased phosphoryla-
tion at this site with a decrease in VSMC growth, and possibly as
shown earlier in the cardiomyocytes (Kwak et al., 1995; Kwak and
Jongsma, 1996) the Cx43 in the cardiovascular system may behave
differently than in other cell/tissue types.
It should be noted that the primary cells used in this study were
derived from thoracic aorta.VSMCs of both resistance and conduit
arteries express predominantly Cx43 and Cx45 (Little et al., 1995),
and the expression of connexin proteins has been reported to vary
particularly in arterioles and small arteries (Schmidt et al., 2008).
In addition to this potential vascular heterogeneity among con-
nexin isotypes, it is important to note that connexins in the intimal
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endothelium and adjacent medial wall are critical in the regulation
of gross vessel function. Vasoconstrictor and vasodilatory signals
travel rapidly along the vessel network due to the conduction of
signals between endothelial and smooth muscle cells (Beny and
Connat, 1992), and these occur through gap junctions. The spread
of conducted dilations which travel large distances along the ves-
sel are facilitated more by the endothelium, whereas conducted
constrictions rely primarily on the smooth muscle. Even though
the anatomical characteristics of endothelial cells may provide a
more efficient pathway to coordinate vascular behavior (Haas and
Duling, 1997), in this study the focus was on connexin physiology
of medial wall-derived VSMCs.
It should also be noted that for many of the endpoints ana-
lyzed in this study, the overall changes generally ranged between
20 and 40% (with exceptions with the GJIC and inhibitor studies
which demonstrated larger effects), and this may raise concerns
over their physiological relevance. In comparison, the original
characterization of DADS as an inducer of both Cx43 expression
and functionality (Huard et al., 2004) reported increases in GJIC
between 10 and 30% after 8-h treatment with DADS and 50%
after 24 h, agreeing closely with observations in the current study.
Thus, in comparison with this original report using DADS as a
stimulatory agonist, in the current study the observed changes are
considered highly significant and physiologically relevant.
In summary, this study demonstrates a critical role of Cx43
in growth of primary VSM and supports a direct correlation
between proliferation and Cx43 expression and gap junction
communication. It is important to note that increased expres-
sion alone may not lead to increased gap junction communi-
cation, and that opening of the channels with functional con-
ductance is the rate-limiting step in cell–cell communication.
In this study Cx43-mediated GJIC was found to operate inde-
pendently of site-specific Cx43 phosphorylation, demonstrating
that the role of Cx43 phosphorylation may be mostly depen-
dent on the type of cell/tissue. These findings may open new
avenues for further understanding the factors that regulate VSMC
growth.
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